Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sichuan Biaoxin Pharmaceutical Technology is a specialized Contract Research Organization (CRO) based in Chengdu, China, focusing on pharmaceutical analysis and CMC services. The company provides comprehensive technical support for drug development, including the synthesis of impurity reference standards, quality control methodology, and stability testing. They play a significant role in the consistency evaluation of generic drugs, helping pharmaceutical manufacturers meet stringent regulatory standards. Biaoxin operates a dedicated research platform for impurity identification and characterization, serving a broad client base in the life sciences sector. Their expertise extends to the development of high-end pharmaceutical intermediates and the provision of technical consulting for drug registration.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sichuan Biaoxin Pharmaceutical Technology.